This pathway is invaluable for regulating excessive immune responses [6–8]; however, in cancers, tumor cells utilize the suppression of T cells mediated by PD-1/PD-L1 to circumvent anti-tumor immune responses [9–11]. Here, CD274 is linked to cancer.